Sales and Marketing

Showing 15 posts of 11527 posts found.

Quintiles hires head from Deloitte

December 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deloitte, Quintiles

Contract research organisation Quintiles has appointed Scott Evangelista as its president for Integrated Commercial Services and Solutions.  The firm said …

Merck develops diabetes game

December 17, 2013 Medical Communications, Sales and Marketing Gamification, Merck, ayogo, diabetes, type 2

Merck has announced it is working with digital health specialist Ayogo to develop a new game aimed at helping type …

Europe to vote on greater trial transparency

December 17, 2013 Research and Development, Sales and Marketing EU, Europe, Goldacre, alltrials, transparency

Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …

GSK changes sales tactics

December 17, 2013 Medical Communications, Sales and Marketing GSK, Witty, bribery, corruption, cuts, sales, transparency

GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products.  The UK …

Teva vice chairman quits

December 17, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, amir elstein, moshe many

Teva Pharmaceuticals vice chairman Professor Moshe Many has requested to leave the firm at the end of this month for …

Novartis shuts plant in Canada cutting 300 jobs

December 16, 2013 Manufacturing and Production, Sales and Marketing Canada, Novartis, Ontario, cuts, lens, manufacturing

Novartis is shutting down its manufacturing plant in Canada which will result in 300 people losing their jobs at the …

NICE must get tougher on pharma, urges BMJ journal

December 16, 2013 Sales and Marketing BMJ, NHS, NICE, pharma

The UK should have one universal health technology assessor which should seek to tighten up rules on whether new drugs …

BMS appoints Thomas Lynch to board

December 16, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, lynch

Bristol-Myers Squibb has elected Thomas Lynch to its board to serve as a member on its Science and Technology Committee …

The year in review 2013

December 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2014, NHS, Obama, adams, review of the year

The year 2013 brought a new series of challenges for pharma. As the dust settled following the bulk of major …

Chiesi publicly reprimanded

December 13, 2013 Sales and Marketing ABPI, Chiesi, PMCPA, fostair

Chiesi has had the book thrown at it by the PMCPA and faces the shame of a public reprimand – …

Sanofi escapes most serious censure

December 13, 2013 Medical Communications, Sales and Marketing ABPI, Lyxumia, PMCPA, Sanofi, censure

Sanofi has been cleared of the most serious breach of the ABPI Code of Practice – despite appearing to offer …

McCann Health names president of New York unit

December 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing duffy, mccann

Comms giant McCann Health has hired Susan Duffy to be president of its New York-based McCann Regan Campbell Ward (RCW). …

AstraZeneca donates doomed lab to Plymouth University

December 12, 2013 Research and Development, Sales and Marketing AstraZeneca, lab, plymouth, university

AstraZeneca has pledged to donate its Devon-based Environmental Laboratory to Plymouth University, after announcing the site’s closure in October. The …

€16 million fines for J&J and Novartis

December 12, 2013 Medical Communications, Sales and Marketing EU, J&J, JJ, Novartis, Sandoz, fentanyl, fines

The European Commission has slapped multi-million euro fines on Johnson & Johnson and Novartis for what it says were ‘shocking’ …

GSK funnels another £200m into UK manufacturing

December 12, 2013 Manufacturing and Production, Sales and Marketing GSK, Taylor, UK, manufacturing

GlaxoSmithKline has made good on a pledge to invest in UK-based production, with £200 million ($328m) earmarked for plant upgrades …
The Gateway to Local Adoption Series

Latest content